255 related articles for article (PubMed ID: 25786915)
21. HER2-mediated enhancement of Ebola virus entry.
Kuroda M; Halfmann P; Kawaoka Y
PLoS Pathog; 2020 Oct; 16(10):e1008900. PubMed ID: 33052961
[TBL] [Abstract][Full Text] [Related]
22. RNA binding motif 4 inhibits the replication of ebolavirus by directly targeting 3'-leader region of genomic RNA.
Fan L; Wang Y; Huang H; Wang Z; Liang C; Yang X; Ye P; Lin J; Shi W; Zhou Y; Yan H; Long Z; Wang Z; Liu L; Qian J
Emerg Microbes Infect; 2024 Dec; 13(1):2300762. PubMed ID: 38164794
[TBL] [Abstract][Full Text] [Related]
23. Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release.
Heidecker G; Lloyd PA; Fox K; Nagashima K; Derse D
J Virol; 2004 Jun; 78(12):6636-48. PubMed ID: 15163754
[TBL] [Abstract][Full Text] [Related]
24. ESCRT requirements for EIAV budding.
Sandrin V; Sundquist WI
Retrovirology; 2013 Oct; 10():104. PubMed ID: 24107264
[TBL] [Abstract][Full Text] [Related]
25. Budding of Tiger Frog Virus (an Iridovirus) from HepG2 Cells via Three Ways Recruits the ESCRT Pathway.
Mi S; Qin XW; Lin YF; He J; Chen NN; Liu C; Weng SP; He JG; Guo CJ
Sci Rep; 2016 May; 6():26581. PubMed ID: 27225426
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release.
Jayakar HR; Murti KG; Whitt MA
J Virol; 2000 Nov; 74(21):9818-27. PubMed ID: 11024108
[TBL] [Abstract][Full Text] [Related]
27. High-throughput virtual screening and docking studies of matrix protein vp40 of ebola virus.
Tamilvanan T; Hopper W
Bioinformation; 2013; 9(6):286-92. PubMed ID: 23559747
[TBL] [Abstract][Full Text] [Related]
28. The Ebola virus protein VP40 hexamer enhances the clustering of PI(4,5)P
Gc JB; Gerstman BS; Stahelin RV; Chapagain PP
Phys Chem Chem Phys; 2016 Oct; 18(41):28409-28417. PubMed ID: 27757455
[TBL] [Abstract][Full Text] [Related]
29. Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum.
Bhattacharyya S; Hope TJ
Virol J; 2011 Jan; 8():11. PubMed ID: 21223600
[TBL] [Abstract][Full Text] [Related]
30. An Antiviral Role for TRIM14 in Ebola Virus Infection.
Kuroda M; Halfmann PJ; Thackray LB; Diamond MS; Feldmann H; Marzi A; Kawaoka Y
J Infect Dis; 2023 Nov; 228(Suppl 7):S514-S521. PubMed ID: 37562033
[TBL] [Abstract][Full Text] [Related]
31. Evolutionary conservation of Ebola virus proteins predicts important functions at residue level.
Arslan A; van Noort V
Bioinformatics; 2017 Jan; 33(2):151-154. PubMed ID: 27659453
[TBL] [Abstract][Full Text] [Related]
32. ZMapp reduces diffusion of Ebola viral particles in fresh human cervicovaginal mucus.
Schaefer A; Yang B; Schroeder HA; Harit D; Humphry MS; Zeitlin L; Whaley KJ; Ravel J; Fischer WA; Lai SK
Emerg Microbes Infect; 2024 Dec; 13(1):2352520. PubMed ID: 38713593
[TBL] [Abstract][Full Text] [Related]
33. Contrasting effects of filamin A and B proteins in modulating filovirus entry.
Shepley-McTaggart A; Liang J; Ding Y; Djurkovic MA; Kriachun V; Shtanko O; Sunyer O; Harty RN
PLoS Pathog; 2023 Aug; 19(8):e1011595. PubMed ID: 37585478
[TBL] [Abstract][Full Text] [Related]
34. Ebola Virus Infection Induces HCAR2 Expression Leading to Cell Death.
Kuroda M; Halfmann PJ; Kawaoka Y
J Infect Dis; 2023 Nov; 228(Suppl 7):S508-S513. PubMed ID: 37578011
[TBL] [Abstract][Full Text] [Related]
35. Reporter Assays for Ebola Virus Nucleoprotein Oligomerization, Virion-Like Particle Budding, and Minigenome Activity Reveal the Importance of Nucleoprotein Amino Acid Position 111.
Lin AE; Diehl WE; Cai Y; Finch CL; Akusobi C; Kirchdoerfer RN; Bollinger L; Schaffner SF; Brown EA; Saphire EO; Andersen KG; Kuhn JH; Luban J; Sabeti PC
Viruses; 2020 Jan; 12(1):. PubMed ID: 31952352
[TBL] [Abstract][Full Text] [Related]
36. An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells.
Cai Y; Yu S; Chi X; Radoshitzky SR; Kuhn JH; Berger EA
PLoS One; 2021; 16(1):e0245024. PubMed ID: 33411835
[TBL] [Abstract][Full Text] [Related]
37. Ebola Virus Uses Tunneling Nanotubes as an Alternate Route of Dissemination.
Djurkovic MA; Leavitt CG; Arnett E; Kriachun V; Martínez-Sobrido L; Titone R; Sherwood LJ; Hayhurst A; Schlesinger LS; Shtanko O
J Infect Dis; 2023 Nov; 228(Suppl 7):S522-S535. PubMed ID: 37723997
[TBL] [Abstract][Full Text] [Related]
38. Structural studies on the Ebola virus matrix protein VP40 indicate that matrix proteins of enveloped RNA viruses are analogues but not homologues.
Timmins J; Ruigrok RW; Weissenhorn W
FEMS Microbiol Lett; 2004 Apr; 233(2):179-86. PubMed ID: 15108720
[TBL] [Abstract][Full Text] [Related]
39. Ebolaviruses: New roles for old proteins.
Cantoni D; Rossman JS
PLoS Negl Trop Dis; 2018 May; 12(5):e0006349. PubMed ID: 29723187
[TBL] [Abstract][Full Text] [Related]
40. Development of a Multivalent Kunjin Virus Reporter Virus-Like Particle System Inducing Seroconversion for Ebola and West Nile Virus Proteins in Mice.
Tran PT; Asghar N; Höglund U; Larsson O; Haag L; Mirazimi A; Johansson M; Melik W
Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33260425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
